What You Should Know:
- Podimetrics raises $45M to help at-risk providers and health plans prevent diabetic amputations in high-risk patients.
- With this latest round of funding, Podimetrics plans to focus on hiring to build out their product development and research teams, while also expanding the breadth of services delivered by their nurse support team.
Podimetrics, a care management company with the leading solution to help prevent costly and deadly diabetic foot ulcer (DFUs)
Read More
Diabetes| Type 1 & 2 Diabetes Management | Policy, News, Analysis, Insights - HIT Consultant
9am.health, Ascensia Partner to Expand Virtual Diabetes Clinic
What You Should Know:
- 9am.health today announced it is expanding its virtual diabetes clinic through a strategic partnership with Ascensia to add the CONTOUR®NEXT ONE Blood Glucose Meter to Its patient toolkit.
- 9am.health patients can now conveniently add Ascensia Diabetes Care’s blood glucose meter and test strips to their personalized treatment plan, with the meter offered free of charge to all patient care plans. The test strip add-on is available through a
Read More
Early Use of Diabetes Technology Drives Better Patient Outcomes in Kids
A recent study from Stanford found that pediatric patients with rapid access to continuous glucose monitoring soon after a type 1 diabetes diagnosis had healthier blood sugar values than an earlier group of patients who weren’t given the monitors near the time of diagnosis.
The research provides an example of how the healthcare industry is evolving to use technology: It provides more frequent touchpoints with caregivers, makes quality care available to a larger number of patients, and
Read More
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
Glooko Acquires DIABNEXT to Expand Diabetes Offerings in France
What You Should Know:
Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can improve health outcomes.
- DIABNEXT’s mobile app complements Glooko’s product portfolio and tracks diabetes data so that
Read More
Why The End of the Public Health Emergency is Everyone’s Problem
The COVID-19 pandemic led to sweeping healthcare policy changes that enable vulnerable Americans to receive affordable health coverage and access essential safety net benefits. The steep incline in unemployment and fears that millions of people would lose their health coverage drove the declaration of the national public health emergency (PHE) on January 31, 2020. Under the PHE, states must keep Medicaid enrollees continuously covered, irrespective of their circumstances.
With the PHE set
Read More
DarioHealth Forms $30M Strategic Agreement with Sanofi U.S.
What You Should Know:
- DarioHealth Corp., a provider of global digital therapeutics (DTx), announced it has entered into a $30M multi-year, strategic agreement with Sanofi U.S., an innovative global healthcare company. The multi-year, $30 million-dollar agreement will help accelerate commercial adoption of Dario's full suite of digital therapeutics and drive the expansion of digital health solutions on the Dario platform.
- As part of the strategic agreement, Dario and Sanofi will
Read More
CVS Health Releases Drug Trend Report
What You Should Know:
- CVS Health released their Drug Trend Report, examining the drivers of overall and specialty drug trend through the first three quarters of 2021. Data were calculated on a cohort of 1,014 PBM clients—employers and health plans—covering approximately 22 million lives.
- The report details how CVS Health delivered an overall drug trend of 2.4% for commercial PBM clients, with 35.9% having a
Read More
Omada Health Raises $192M to Expand Digital Therapeutics for Chronic Disease
What You Should Know:
- Omada Health, a chronic care integrated healthcare provider, today announced its $192M in Series E funding round led by Fidelity Management & Research Company with participation from aMoon, existing investors Perceptive Advisors, Wellington Management, Civilization Ventures, and others.
- Omada Health will utilize the funding to accelerate hiring at all levels to meet growing customer demands, a technological roadmap for care and coaching personalization to
Read More
EarliTec Diagnostics Raises $19.5M to Advance Autism Diagnosis and Treatment in Children
What You Should Know:
- EarliTec Dx, a digital health company developing novel diagnostic and therapeutic products for children with Autism Spectrum Disorder (ASD) and early childhood vulnerabilities, today announced a $19.5 million financing led by Bernie Marcus, with participation from the Georgia Research Alliance (GRA).
- This round of financing will be used to support filing with the U.S. Food and Drug Administration (FDA) for 510K clearance, as well as commercialization of the
Read More
